-

Thermo Fisher Scientific Announces a New-Generation, Fully Automated (S)TEM Metrology Solution for Increased Productivity and Data Quality Assurance in Semiconductor Manufacturing

Thermo Scientific Metrios 6 Scanning Transmission Electron Microscope ((S)TEM) is designed to meet an industry need for faster access to large-volume, high-quality data; newly designed hardware and advanced machine learning techniques aim to optimize performance and reduce operating expenses

HILLSBORO, Ore.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Metrios™ 6 Scanning Transmission Electron Microscope ((S)TEM) — a new-generation, fully automated (S)TEM metrology solution designed to help enhance productivity and deliver data quality assurance for high-volume semiconductor manufacturing.

The Metrios 6 (S)TEM enables fully automated TEM metrology and characterization workflows with up to 20% in average productivity improvement compared to the previous generation of the Thermo Scientific Metrios (S)TEM.

The more complex the semiconductor device 3D architecture, the more exact the in-depth metrology and characterization processes must be. As a proven leader in high-impact innovation, Thermo Fisher sees firsthand that the atomic-scale 3D intricacies in today’s devices are driving a need for a highly automated (S)TEM platform to enable faster access to large-volume, high-quality data and help accelerate learning cycles.

Built to increase productivity and accelerate data acquisition—therefore facilitating yield improvements and reducing time-to-market—the Metrios 6 (S)TEM incorporates industry-leading hardware and machine-learning algorithms to obtain large-volume high-quality data from complex devices and novel materials rapidly.

“Manufacturing semiconductors in today’s increasingly complex technological landscape demands not only high throughput and resource optimization, but also a larger volume of TEM data than ever before," said Mohan Iyer, vice president and general manager, semiconductor, at Thermo Fisher Scientific. "To address these challenges, we are proud to introduce the Metrios 6 automated (S)TEM metrology solution that boosts productivity through innovative hardware advancements and powerful software enhancements. With the Metrios 6 microscope, semiconductor manufacturers can now access actionable data faster, while simultaneously increasing tool and human resource productivity, thus accelerating semiconductor development cycles."

New features and capabilities compared to previous Metrios generations include:

  • Smart Stage fully automated sample insertion and retraction mechanism eliminates manual operation and potential for human errors, enabling customers to perform high-resolution imaging at a faster pace.
  • New Thermo Scientific Ultra-X EDS detection system offers fast compositional characterization and elemental mapping to ease challenging analysis on the most beam-sensitive materials and enable at least two times faster data collection.
  • Newly designed objective lens and source innovations enable voltage switching in minutes versus hours, higher-efficiency (S)TEM and EDS acquisition and uncompromised resolution.
  • Machine-learning-enabled automation eliminates tedious recipe generation for routine (S)TEM analysis and provides automated workflows with flexibility to generate large volume data without using highly skilled operators.

Learn more about the Thermo Scientific Metrios 6 (S)TEM: https://ter.li/83u7c5

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Brianna Radicioni
Thermo Fisher Scientific
+1 617-390-3924
Brianna.radicioni@thermofisher.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Brianna Radicioni
Thermo Fisher Scientific
+1 617-390-3924
Brianna.radicioni@thermofisher.com

Social Media Profiles
More News From Thermo Fisher

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desig...

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000%...

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors wi...
Back to Newsroom